RT Book, Section A1 Meyer, Jonathan M. A2 Brunton, Laurence L. A2 Hilal-Dandan, Randa A2 Knollmann, Björn C. SR Print(0) ID 1162535494 T1 Pharmacotherapy of Psychosis and Mania T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9781259584732 LK hemonc.mhmedical.com/content.aspx?aid=1162535494 RD 2024/10/15 AB AbbreviationsACEI: angiotensin-converting enzyme inhibitorAUC: area under the curveCBC: complete blood cell countCNS: central nervous systemCOX-2: cyclooxygenase 2CV: cardiovascularDA: dopamineDAAO:D-amino acid oxidaseDAT: DA transporterDM: diabetes mellitusECG: electrocardiogramECT: electroconvulsive therapyeGFR: estimated glomerular filtration rateEM: extensive metabolizerENaC: epithelial sodium channelEPS: extrapyramidal symptomFDA: Food and Drug AdministrationG-CSF: granulocyte colony-stimulating factorGFR: glomerular filtration rateGlyT: glycine transporterGSK: glycogen synthase kinase5HT: serotoninIkr: inwardly rectifying K+ channelsIM: intramuscularLAI: long-acting injectableMAO: monoamine oxidasemGlu: metabotropic glutamateNDI: nephrogenic diabetes insipidusNE: norepinephrineNMDA:N-methyl-D-aspartateNMS: neuroleptic malignant syndromeODT: oral dissolving tabletPDP: Parkinson disease psychosisPET: positron emission tomographyPGP: P-glycoproteinPK_: protein kinase _, as in PKA, PKCPP2A: protein phosphatase 2ASCD: sudden cardiac deathT4: levorotatory thyroxineTD: tardive dyskinesiaTH: tyrosine hydroxylaseTSH: thyrotropin (previously thyroid-stimulating hormone)VMAT2: vesicular monoamine transporter 2